Management of Venous Thromboembolism (VTE) in Ambulatory Patients with Cancer is organized by i3 Health. This Conference has been approved for a maximum of 1.0 ANCC contact hour.
August 16, 2017 - August 15, 2019
Nurses, nurse practitioners, and clinical nurse specialists.
Venous thromboembolism (VTE) is a common and potentially life-threatening complication in patients with cancer. There are two main types of VTE: deep vein thrombosis (DVT) and pulmonary embolus (PE), which can cause right heart failure, cardiopulmonary collapse, and death (Ozaki & Bartholomew, 2012). Patients who develop PE require hospitalization, increased oxygen requirements, and the need for temporary and/or long-term anticoagulation. These complications, in turn, lead to delays in receipt of cancer therapy, an increased risk for VTE recurrence, increased risk of morbidity and mortality, decreased quality of life, and increased health care costs (Lee & Peterson, 2013). Early identification of ambulatory chemotherapy patients at high risk for VTE will help the health care team to prescribe prophylaxis in a timely and appropriate manner, avoid use when inappropriate, and ultimately reduce the number of patients who experience VTE during their cancer treatment.
Upon completion of this activity, participants should be able to:
• Describe pathophysiology of VTE
• Assess VTE risk in patients receiving ambulatory chemotherapy
• Apply current VTE guidelines in the management of patients receiving ambulatory chemotherapy
Additional details will be posted as soon as they are available.
Cardiology, Oncology, Healthcare Management